Tolerance and use eucerin atopicontrol in treatment atopic dermatitis in children treated in dermatology serviceinsn during the months of july - october 2021

Authors

  • Rosalía Ballona Servicio de Dermatología, Instituto Nacional de Salud del Niño, Lima, Perú
  • Rosario Torres Servicio de Dermatología, Instituto Nacional de Salud del Niño, Lima, Perú
  • Felipe Velásquez Servicio de Dermatología, Instituto Nacional de Salud del Niño, Lima, Perú
  • Johanna Peceros Servicio de Dermatología, Instituto Nacional de Salud del Niño, Lima, Perú
  • Reinaldo Pomar Servicio de Dermatología, Instituto Nacional de Salud del Niño, Lima, Perú
  • Consuelo Apagueño Servicio de Dermatología, Hospital Alberto Sabogal, Lima, Perú

DOI:

https://doi.org/10.61651/rped.2022v74n1p16-22

Keywords:

Dermatitis, Atopic, Child, Emollients

Abstract

Objective: Confirm the tolerance and safety of the use of Eucerin AtopiControl, in children with a diagnosis of Atopic Dermatitis: Eucerin AtopiControl Cream (acute phase), AtopiControl Balsam (maintenance phase)

Material and methods: Study open, prospective, descriptive, without a control group, was carried out in the private offices of Pediatric Dermatologists, during the months of July to October 2021. We included 41 patients with a diagnosis of Atopic Dermatitis: Moderate (60% ) and Severe (31 %).Were women 53.6% and women, 46.3% were men, and 56.3% of them were under 2 years of age. They were evaluated in 4 visits, every 15 days, and the patients received Eucerin Atopi Control Cream, twice a day, in the first visit, and AtopiControl Balsam in the 3 following visits, a very good response was evidenced, with improvement in the Scorad and the IGA. Itching control from the first week as well as an improvement in sleep.

Conclusion: It is evidenced that Eucerin AtopiControl both in cream and in body balm, provides clinical efficacy and safety, is well tolerated in pediatric patients and constitutes an effective alternative in the control of Atopic Dermatitis.

Downloads

Download data is not yet available.

Downloads

Published

2022-12-31

How to Cite

1.
Ballona R, Torres R, Velásquez F, Peceros J, Pomar R, Apagueño C. Tolerance and use eucerin atopicontrol in treatment atopic dermatitis in children treated in dermatology serviceinsn during the months of july - october 2021. Rev Peru Pediatr [Internet]. 2022 Dec. 31 [cited 2025 May 19];74(1):16-22. Available from: https://pediatria.pe/index.php/pedperu/article/view/339

Issue

Vol. 74 Num. 1 (2022)

Section

ORIGINAL ARTICLE

Categories

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors will retain the copyright and grant the right to publish their work in the journal while allowing third parties to share it under the Creative Commons Attribution license.

Articles are published under a Creative Commons license that allows sharing and adaptation with appropriate credit. CC BY 4.0 license. Available in English at https://creativecommons.org/licenses/by/4.0/

Authors may use other information disclosure formats as long as the initial publication in the journal is cited. The dissemination of the work through the Internet is recommended to increase citations and promote academic exchanges.

The published content does not necessarily reflect the specific point of view of the journal, and the authors assume full responsibility for the content of their article.